“We are what we repeatedly do. Excellence, then, is not an act, but a habit.”

―Aristotle

The entire team is ecstatic about winning the "Best Big Data Reporting & Analytics Solution" award at this years SIIA CODiE awards. This was announced at the  Business Technology & Company CODiE Award Winner Announcement Party at San Francisco. LexisNexis PatentSight was announced one of three finalists earlier this year, in May. The first-round review of all nominees is conducted by software and business technology experts with considerable industry expertise, including members of the industry, analysts, media, bloggers, bankers and investors. The scores from the expert judge review determine the finalists. SIIA members then vote on the finalist products, and the scores from both rounds are tabulated to select the winners. We’re honored and humbled to be receiving the CODiE Award and congrats to all the other winners.

The Press Release of FCA’s proposal for a ‘transformative merger’ with Groupe Renault brings forth the possibility of major change of scenario in the global automotive industry. The proposed merged entity is to be split equally between FCA and Renault shareholders. The merger is expected to allow the combined companies to have greater market coverage in terms of span of automotive technologies and global presence. As claimed by FCA, a noteworthy point in this proposal is the predicted incremental value expected to be routed to Nissan and Mitsubishi as members of the Renault-Nissan-Mitsubishi alliance.

"Success in creating AI would be the biggest event in human history. Unfortunately, it might also be the last, unless we learn how to avoid the risks."

- Stephen Hawking

Despite its wide-spread adoption and further sub-technologies being developed over the years, the field of AI has remained murky to outsiders. For generations, Artificial Intelligence or AI has been depicted to the general public as a threat to our existence or as a superior being which deems our species unworthy of the planet. There exists a definite lack of precise definition of the field and there is little, to no information regarding where the world nations are at with respect to developing the technology.

In pursuit of enhancing the clarity on this topic, EconSight - a leading Switzerland-based Business Research and Consulting firm, partnered with PatentSight and the Swiss Federal Institute of Intellectual Property to conduct a deep-dive into the technology field of Artificial Intelligence. Kai Gramke, who is the CEO at EconSight, presented the findings from the study at the PatentSight Summit 2019.

“Being at least as good as the leader is a prerequisite to being competitive.”
— Peter Drucker

 Among the various uses for the Patent Asset Index™, one major area of application is in portfolio Benchmarking. Any company operating in the modern day sets goals for themselves, to guide them towards the success that they strive to achieve. Our unparalleled data quality and multi-pronged analysis tools ensure that decision makers get the right information at the right time to make decisions about the right goals to set.  

In a newly released whitepaper PatentSight takes a deep dive into the portfolio of Palantir – one of Silicon Valley’s most secretive companies – to demonstrate how advanced patent analytics can be used to provide critical insights for investment decisions.

Ranked among the top 10 global medical device companies as of revenue, General Electric is now about to file for an IPO to spin out its health-care unit GE Healthcare, as reported by CNBC. With the ongoing jump of Siemens Healthineers shares after their $5 Billion IPO, now GE Healthcare has caught the attention of investors in the medical device market. In this context, PatentSight shed light on the global top 10 medical device companies as of revenue in 2017 from a patent perspective.

Recently, we applied the PatentSight Patent Asset Index methodology to gain a new insight into which of Israel’s research bodies are leading in innovation. The index assesses the strength of an organization’s patent portfolio in terms of quality of patents held measured by TechnologyRelevance™ and Market Coverage ™. So, what did we find?

End of February 2019 Samsung revealed its long rumored smart phone with a foldable display, the first of its kind to have an official release date. A number of players have been rumored to be working on such devices, however Samsung’s combination of in-house smartphone and display technologies may have led to it being first to market.

A closer look at the innovation landscape and the qualitative strength of the patent portfolios in the field of foldable smartphone technology shows the enormous lead Samsung has and the areas in which Apple has to catch up.

In January of this year, U.S. pharmaceutical manufacturers Bristol-Myers Squibb (BMS) and Celgene Corporation announced they had entered into a definitive merger agreement for BMS to acquire Celgene.

The stated aim of the merger is to create ‘a premier innovative biopharma company’ with a particular focus on building an expanded offering in the cancer and immunotherapy space. If completed, the transaction is expected to cost $74 billion in a cash and stock deal, whereby Celgene shareholders will receive 1.0 BMS share as well as $50 in cash for each share of Celgene.

Our analysis of the two firms’ respective patent portfolios provides insight into how this merger would affect the U.S. pharma market. For this analysis, we employed our Patent Asset Index^TM methodology, which scientifically assesses patent families against Key Performance Indicators of Technology Relevance^TM and Market Coverage^TM.

With the acquisition of Maxwell Technologies, Tesla expands its patent portfolio and includes technologies that may lead to a major advantage in the future technology of efficient batteries for electric cars. The company is a specialist in the field of energy storage. For Tesla this can mean a leap forward in the highly competitive field of battery technology for electric cars. A closer look at this acquisition scenario shows us in which technology areas Maxwell can significantly complement Tesla's patent portfolio.